QA: EYENOVIA INC. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001682639_2023_EYENOVIA_INC.pdf

Logs

Graph

Absolute values for 0001682639, EYENOVIA INC.

  xvar xval
0 AssetsCurrent 27,642,506
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,295,115
3 remainder_Assets 2,098,792
4 LiabilitiesCurrent 4,512,328
5 LiabilitiesNoncurrent 907,644
6 remainder_Liabilities 8,381,876
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 13,532,835
9 ResearchAndDevelopmentExpense 13,378,680
10 remainder_Expenses 1,380,058
11 remainder_Revenues 0
12 remainder_NetIncome 280,416
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 31,036,413
1 Liabilities 13,801,848
2 Expenses 28,291,573
3 Revenues 0
4 StockholdersEquity 17,234,565
5 NetIncome -28,011,157
6 ComprehensiveNetIncome -28,011,157
7 BaseVar 36,705,125
8 EconomicCapitalRatio 0.0728

Edgar->Model Mapping

Feature Distribution

Change over Time